Enzymatica
1,94 SEK -2,02%Vær den første som følger denne virksomhed
Enzymatica is a life science company that develops and sells medical devices for infection-related diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray which can prevent colds as well as shorten the illness period. The product has been launched on several markets and the strategy is to expand to more markets via partners. The company is headquartered in Lund.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ENZY
Daglig lav / høj pris
1,88 / 1,97
SEK
Markedsværdi
336,36 mio. SEK
Aktieomsætning
191,99 t SEK
Volumen
101 t
Finanskalender
Ekstraordinær generalforsamling
06.08.2024
Delårsrapport
07.11.2024
Årsrapport
18.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Mats Andersson, privat och genom bolag | 22,4 % | 22,4 % |
Roosgruppen AB | 13,6 % | 13,6 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Enzymatica AB: Enzymatica's Board of Directors updates the financial targets
Notice of Extraordinary General Meeting in Enzymatica AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools